RedHill Biopharma reported $1.2M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cara Therapeutics USD 46M 23M Jun/2025
Clal Biotechnology ILS 47.99M 4.37M Jan/2026
Compugen USD 137.5M 21.89M Sep/2025
Cronos Group USD 1.06B 319.22M Sep/2025
RedHill Biopharma USD 12M 17M Jun/2024